Immune Response of Haemodialysis Patients Post Covid-19 Vaccination

N/AUnknownNCT04872751

Penang Hospital, Malaysia425 enrolled

Overview

The purpose of this study is to assess immune response of end stage renal failure patients after Covid 19 vaccination

Study Type

OBSERVATIONAL

Enrollment

425

Conditions

Immune Response Post Covid 19 Vaccination

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ESRF patient on hemodialysis who are eligible for the goverment Covid 19 vaccination programme * 18 years old and above * consented to join the study Exclusion Criteria: * patient who refused to be vaccinated * patient who deemed unsuitable for Covid vaccination

Locations (1)

Penang Hospital

George Town, Pulau Pinang, Malaysia

RECRUITING

Outcomes

Primary Outcomes

Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level

Study the antibody synthesis induced by vaccination, among end stage renal failure patients, and the change in its level at 1 month, at 6 months and at 1 year after complete vaccination.

Time frame: up to one year

Secondary Outcomes

Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level after 1st inoculation of the vaccine (incomplete vaccination)

Study the antibody synthesis and the change in its level after 1st inoculation of the vaccine

Time frame: one month

Central Contacts

XueFang Tan

CONTACT

6042225333 xf821020@hotmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.